文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

根据标准液体治疗强度分层的IV液体限制对脓毒性休克ICU患者的影响:CLASSIC试验站点分析

Effects of IV Fluid Restriction According to Standard Fluid Treatment Intensity Across Conservative Versus Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC) Trial Sites.
PubMed 文献 · Crit Care Med · 2025-04-24
一句话结论CLASSIC试验二次分析显示,在脓毒性休克成人ICU患者中,各站点标准IV液体量的差异未实质性影响液体限制对结局的作用。

该研究为CLASSIC随机临床试验的二次分析,纳入19个站点共1366例成人脓毒性休克ICU患者,占全试验人群88%。研究使用机器学习预测标准液体组前24小时IV液体量,并根据预测与实施量的均值差异将站点分为五个强度亚组。结果显示,各强度亚组间死亡率绝对差异范围为-2.7%至1.4%,限制性vs标准IV液体治疗对所有结局的影响相似。结论认为,在考虑患者特征后,站点间标准IV液体量的差异未实质性影响液体限制的效果。

要点

  • 在19个站点1366例脓毒性休克ICU患者中,标准液体组实施与预测IV液体量中位绝对差异为-118 mL(IQR -1341至1731 mL)。
  • 按标准液体治疗强度分为五个亚组,各亚组间死亡率绝对差异范围为-2.7%至1.4%。
  • 限制性vs标准IV液体治疗在五个强度亚组内对所有结局(死亡率、严重不良事件、无生命支持存活天数、出院存活天数)的影响相似。
  • 敏感性分析中分别在各站点评估干预效果,结果与主要分析相似。
  • 作者结论:站点间标准IV液体量的差异未实质性影响液体限制对脓毒性休克ICU患者结局的作用。

适用人群与场景

  • CLASSIC试验纳入的成人ICU脓毒性休克患者,本二次分析纳入19个站点共1366例参与者,占全试验人群88%,仅纳入标准液体组中大于或等于15例参与者的站点。

处置流程与药物剂量

  • 干预为限制性vs标准IV液体治疗。

研究设计与关键结果

  • 研究设计为随机临床试验的二次分析,纳入19个站点1366例成人ICU脓毒性休克患者,占全试验人群88%,仅纳入标准液体组中大于或等于15例参与者的站点。
  • 使用机器学习(eXtreme Gradient Boosting)预测标准液体组前24小时IV液体量,并考虑可能贡献治疗变异的参与者特征。
  • 根据标准液体组前24小时预测与实施IV液体量的均值差异,将站点分为五个强度亚组。
  • 标准液体组中,实施与预测IV液体量中位绝对差异为-118 mL(四分位距-1341至1731 mL;全距-5873至11761 mL)。
  • 各强度亚组间死亡率绝对差异范围为-2.7%至1.4%。
  • 使用分层贝叶斯模型(弱信息先验)评估干预对死亡率、严重不良事件和反应、第90天无生命支持存活天数及出院存活天数的影响,发现在各强度亚组内限制性vs标准IV液体治疗对所有结局影响相似。
  • 敏感性分析分别在各站点评估干预效果,结果相似。

证据类型、等级与局限

  • 证据类型:随机临床试验的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在成人ICU脓毒性休克患者中,考虑患者特征后,站点间标准IV液体量的差异未实质性影响液体限制对结局的作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: In the Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC) trial, restriction of IV fluid volumes led to similar overall mortality in ICU patients with septic shock. We assessed if variation in standard IV fluid treatment intensity across sites impacted the effects of fluid restriction.

DESIGN: Secondary analysis of randomized clinical trial.

PATIENTS: The CLASSIC trial enrolled adult ICU patients with septic shock. We included 1366 participants from 19 sites, representing 88% of the full trial population. All sites with greater than or equal to 15 participants in the standard-fluid group were included in this study.

INTERVENTIONS: Restrictive vs. standard IV fluid therapy.

MEASUREMENTS AND MAIN RESULTS: We used machine learning (eXtreme Gradient Boosting) to predict the IV fluid volumes in the first 24 hours in the standard-fluid group while accounting for participant characteristics that could contribute to treatment variations. We then classified sites into intensity subgroups based on the mean differences between predicted and administered IV fluid volumes in the first 24 hours in the standard-fluid group. We assessed the intervention effects on mortality, serious adverse events and reactions, days alive without life support, and days alive out of hospital at day 90 across these intensity subgroups, using hierarchical Bayesian models with weakly informative priors. Sensitivity analyses evaluated intervention effects separately in each site. In the standard-fluid group, the median absolute difference between administered and predicted IV fluid volumes was -118 mL (interquartile range, -1,341 to 1,731 mL; full range, -5,873 to 11,761 mL). Sites were categorized into five intensity subgroups. The absolute differences in mortality across these subgroups ranged from -2.7% point to 1.4% point. We found similar effects of restrictive vs. standard IV fluid treatment on all outcomes within the intensity subgroups. Results were similar in the sensitivity analyses.

CONCLUSIONS: Among adult ICU patients with septic shock, variation in standard IV fluid volumes across sites did not substantially impact the effects of fluid restriction on outcomes after accounting for patient characteristics.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Sivapalan P, Kaas-Hansen BS, Meyhoff TS, et al. Effects of IV Fluid Restriction According to Standard Fluid Treatment Intensity Across Conservative Versus Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC) Trial Sites. Crit Care Med. 2025. PMID: 40272936. doi:10.1097/CCM.0000000000006679

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。